UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (date of earliest event reported): January 3, 2007

 

ANGIODYNAMICS, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

0-50761
(Commission File Number)		 11-3146460
(IRS Employer Identification No.)


603 Queensbury Avenue, Queensbury, New York
(Address of Principal Executive Offices)		 12804
(Zip Code)		  

(518) 798-1215
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


Item 2.02. Results of Operations and Financial Condition.

Item 7.01. Regulation FD Disclosure.

The following information is furnished pursuant to both Item 2.02 and Item 7.01.

On January 3, 2007, AngioDynamics, Inc. issued a press release announcing its financial results for the thirteen and twenty-six weeks ended December 2, 2006. A copy of the release is attached hereto as Exhibit 99.1 and is incorporated herein by reference in its entirety.

Item 9.01. Financial Statements and Exhibits.

  (d) Exhibits.

  99.1 Press Release issued by AngioDynamics, Inc. on January 3, 2007, regarding financial results for the thirteen and twenty-six weeks ended December 2, 2006.

 

 

2

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 3, 2007

ANGIODYNAMICS, INC.

(Registrant)

 

 

By: /s/ Joseph G. Gerardi                                

Joseph G. Gerardi

Vice President, Chief Financial Officer

 

3

 


EXHIBIT INDEX

 

Exhibit

Description

 

 

99.1.

Press Release issued by AngioDynamics, Inc. on January 3, 2007, regarding financial results for the thirteen and twenty-six weeks ended December 2, 2006.

 

 

4